Tuesday Aug 26
Albany Molecular Research, Inc. (AMRI) CEO To Present At The Morgan...
A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://www.amriglobal.com/investor_relations/AMRI_Webcast_Archive_56_pg.htm .
Mon Aug 18, 2014
Insider Selling: Michael M. Nolan Sells 10,000 Shares of Albany Molecular Research Stock
Albany Molecular Research CFO Michael M. Nolan unloaded 10,000 shares of Albany Molecular Research stock in a transaction dated Thursday, August 14th.
Wed Aug 13, 2014
Albany Molecular Research Director Sells $379,800 in Stock
Albany Molecular Research Director Ambra Thomas E. Phd D sold 20,000 shares of the company's stock in a transaction dated Monday, August 11th.
Albany Molecular Research SVP Lori M. Henderson Sells 30,000 Shares
Albany Molecular Research SVP Lori M. Henderson sold 30,000 shares of the stock on the open market in a transaction dated Tuesday, August 12th.
Tue Aug 12, 2014
Insider Selling: Steven R. Hagen Unloads 10,797 Shares of Albany Molecular Research Stock
Albany Molecular Research SVP Steven R. Hagen unloaded 10,797 shares of the stock in a transaction that occurred on Friday, August 8th.
Albany Molecular Research Downgraded to "Neutral" at Zacks
They currently have a $23.70 price target on the stock. Zacks 's price target would indicate a potential upside of 24.47% from the stock's previous close.
Fri Aug 08, 2014
Regeneron, AMRI find sweet spot as revenues rise
In business the best strategy often involves finding the right size, whether counting employees, making investments or opening new facilities.
Wed Aug 06, 2014
Albany Times Union
AMRI co-founder on pharmacy school's board
Thomas D'Ambra, who cofounded Albany Molecular Research Inc., has been appointed to the board of trustees at Albany College of Pharmacy and Health Sciences.
Injectables outsourcing growing despite pharma M&A, says AMRI
Sterile injectables returning in-house? Not so says AMRI who has entered the sector through the acquisition of CMO Oso Bio Big Pharma is still reliant on CMOs despite talk of returning in-house, says AMRI, which has launched into the top ten manufacturers in the US injectables sector following its recent acquisition.
Tue Aug 05, 2014
Albany Molecular Research Trading Up 8.5% Following Earnings Beat
Albany Molecular Research 's share price was up 8.5% during trading on Tuesday following a better than expected earnings announcement, ARN reports.
Albany Molecular Research, Inc. (AMRI) Announces Second Quarter 2014 Results
Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures, which exclude certain items detailed later in this press release under the heading "Non-GAAP Adjustment Items."
Mon Aug 04, 2014
Catch up on two companies shaping Albany, New York's economy
This is a big week for news on the future of nearly 1,600 jobs at regional operations of Albany Molecular Research Inc. and Regeneron Pharmaceuticals Inc. This is a big week for news on the future of nearly 1,600 jobs at regional operations of Regeneron Pharmaceuticals Inc. The two drug-development companies are expected to release earnings reports ... (more)